Evidence map›Paper›PMID 35216054›Full record

ArticleInternational journal of molecular sciences2022

Membrane Vesicles for Nanoencapsulated Sulforaphane Increased Their Anti-Inflammatory Role on an In Vitro Human Macrophage Model.

Lucía Yepes-Molina, María Isabel Pérez-Jiménez, María Martínez-Esparza, José A Teruel, Antonio J Ruiz-Alcaraz, Pilar García-Peñarrubia, Micaela Carvajal

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Exploring Phenolic Compounds in Crop By-Products for Cosmetic Efficacy.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Article
  10. Article
  11. Small Cellular Particles from European Spruce Needle Homogenate.International journal of molecular sciences · 2023
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lucía Yepes-MolinaAquaporins Group, Centro de Edafología y Biología Aplicada del Segura (CEBAS-CSIC), Campus de Espinardo, 30100 Murcia, Spain.ORCID 0000-0001-6158-6955
María Isabel Pérez-JiménezAquaporins Group, Centro de Edafología y Biología Aplicada del Segura (CEBAS-CSIC), Campus de Espinardo, 30100 Murcia, Spain.ORCID 0000-0001-9509-6268
María Martínez-EsparzaDepartamento de Bioquímica y Biología Molecular (B) e Inmunología, Facultad de Medicina, IMIB and Regional Campus of International Excellence "Campus Mare Nostrum", Universidad de Murcia, 30100 Murcia, Spain.ORCID 0000-0001-5765-8231
José A TeruelDepartamento de Bioquímica y Biología Molecular A, Facultad de Veterinaria, Universidad de Murcia, Campus de Espinardo, 30100 Murcia, Spain.ORCID 0000-0003-2256-3368
Antonio J Ruiz-AlcarazDepartamento de Bioquímica y Biología Molecular (B) e Inmunología, Facultad de Medicina, IMIB and Regional Campus of International Excellence "Campus Mare Nostrum", Universidad de Murcia, 30100 Murcia, Spain.ORCID 0000-0001-6913-0610
Pilar García-PeñarrubiaDepartamento de Bioquímica y Biología Molecular (B) e Inmunología, Facultad de Medicina, IMIB and Regional Campus of International Excellence "Campus Mare Nostrum", Universidad de Murcia, 30100 Murcia, Spain.ORCID 0000-0002-2922-4804
Micaela CarvajalAquaporins Group, Centro de Edafología y Biología Aplicada del Segura (CEBAS-CSIC), Campus de Espinardo, 30100 Murcia, Spain.ORCID 0000-0001-7321-4956
Universidad de Murcia · ESCentro de Edafología y Biología Aplicada del Segura · ES

Funding

Spanish Ministry of Science and Innovation AGL2016-80247-C2-1-RSpanish Ministy of Science and Innovation FPU17/02261
6 · The paper itself

Abstract

At present, there is a growing interest in finding new non-toxic anti-inflammatory drugs to treat inflammation, which is a key pathology in the development of several diseases with considerable mortality. Sulforaphane (SFN), a bioactive compound derived from

Indexed as

Anti-Inflammatory AgentsBrassicaCell Line, TumorCells, CulturedHL-60 CellsHumansInflammationIsothiocyanatesMacrophagesSulfoxidesAnti-Inflammatory AgentsIsothiocyanatessulforaphaneSulfoxidesbroccoliinflammationmacrophagemembrane vesiclesnanocarriersulforaphane

Identifiers

PMID35216054
PMCPMC8878270
OpenAlexW4211166081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.